Transcend Therapeutics

Yale University and Transcend Therapeutics, a rapid-acting psychedelic therapies developer, received a three-year collaborative grant from the U.S. Dept. of Defense (DoD) for a total of $1 million to support their preclinical research on methylone.  The research will assess Transcend...

Transcend Therapeutics closed a Series A funding round of $40 million with leading support from Alpha Wave Global and Integrated Investment Partners.  Founded in 2021 and incubated by leading early-stage VS AlleyCorp, the next-generation psychoactive medicines company has raised nearly $42...